a. 125% increase in HPV-positive oropharyngeal carcinoma, and 50% decrease in HP-negative oropharyngeal carcinoma b. 225% increase in HPV-positive oropharyngeal carcinoma, and 70% decrease in HP-negative oropharyngeal carcinoma c. 225% decrease in HPV-positive oropharyngeal carcinoma, and 50% increase in HP-negative oropharyngeal carcinoma d. 225% increase in HPV-positive oropharyngeal carcinoma, and 50% decrease in HP-negative oropharyngeal carcinoma 4. Which of the following statements is false?
a. There is no significant difference between either of the HRi, HIRi and LIRi groups in the days from commencement of RT until the commencement of feeding tube use to the level of ≥ AEI3, that is greater than or equal to 75% of nutritional requirement b. HPV-positive histology is associated with oropharyngeal carcinoma c. Traditionally, HPV-positive head and neck cancer patients are smokers, aged older than 65 and are female d. In this study, a larger tumour burden is not suggestive of increased weight loss during RT 5. To be eligible for inclusion in this study, patients must have:
a. Undergone either a course of chemoradiotherapy or post-operative radiotherapy b. Undergone a course of IMRT +/À chemotherapy, without therapeutic surgery c. Met the criteria for Low Risk (LRi) of Feeding Tube use d. Must have been offered a prophylactic feeding tube (PEG) and have a tumour of supraglottic, oral cavity, pharyngeal or unknown origin. 
